Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycystic Ovary Syndrome 152 Breast Neoplasms 40 Prostatic Neoplasms 31 Insulin Resistance 30 Obesity 23 Neoplasms 15 Endometrial Neoplasms 15 Pancreatic Neoplasms 14 Infertility 14 Colorectal Neoplasms 13 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Hyperandrogenism 8 Glioblastoma 8 Diabetes Mellitus 8 Squamous Cell Carcinoma of Head and Neck 7 Metabolic Syndrome 7 Melanoma 7 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Ovarian Neoplasms 5 Lymphoma, Large B-Cell, Diffuse 5 Head and Neck Neoplasms 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Uterine Cervical Neoplasms 4 Urinary Bladder Neoplasms 4

Interventions

Surveys and Questionnaires 3 Standard of Care 3 erythromycin propionate-N-acetylcysteinate 1 Therapeutics 1 Surgical Procedures, Operative 1 Quality Assurance, Health Care 1 Practice Guidelines as Topic 1 Palliative Care 1 Midazolam 1 Methods 1 Metformin 1 Mass Screening 1 Interviews as Topic 1 Genes, p53 1 Focus Groups 1 Exercise 1 Dignity Therapy 1 Diet 1 Dexmedetomidine 1 Coping Skills 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Death × Metformin × Clear all

NCT02319200 2017-01-11

METFOVIR

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated

Gastrointestinal

Death, Fibrosis, Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡